Materials
Specialty Chemicals
$65.67B
23K
Key insights and themes extracted from this filing
For the nine months ended 30 June 2025, the company reported a net loss of $364.5 million, a substantial decline from a net income of $1,911.4 million in the prior year. This loss is primarily attributable to $2,952.0 million in pre-tax charges for business and asset actions, including project exit costs, which significantly impacted operating income and net income.
Sales for the three months ended 30 June 2025 increased by 1% to $3,022.7 million from $2,985.5 million in the prior year. However, for the nine months ended 30 June 2025, total consolidated sales were flat at $8,870.4 million compared to $8,913.1 million in the prior year, primarily due to lower volumes from the LNG business divestiture and project exits.
Operating margin for the three months ended 30 June 2025 improved to 26.2%, an increase of 150 basis points from 24.7% in the prior year, reflecting gains from asset sales and cost improvements. However, for the nine months, the company reported a negative operating margin of 10.1% compared to a positive 22.9% in the prior year, primarily due to the large business and asset action charges.